Immunogenicity of a CXCL8-based biopharmaceutical drug candidate in comparison to its wildtype form.
Saved in:
| Title: | Immunogenicity of a CXCL8-based biopharmaceutical drug candidate in comparison to its wildtype form. |
|---|---|
| Authors: | Talker E; Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria., Gerlza T; Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria., Stas P; AlgoNomics, Applied Protein Services, Lonza Biologics PLC, Cambridge, United Kingdom., Trojacher C; Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria., Adage T; Antagonis Biotherapeutics GmbH, Graz, Austria., Kungl AJ; Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.; Antagonis Biotherapeutics GmbH, Graz, Austria. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Dec 16; Vol. 16, pp. 1679409. Date of Electronic Publication: 2025 Dec 16 (Print Publication: 2025). |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1679409 |
